Trial · NCT00500656
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Controlled Phase | STARTED | Randomized Controlled -Icatibant | 36 | |
| Controlled Phase | STARTED | Randomized Controlled-Tranexamic Acid | 38 | |
| Controlled Phase | STARTED | Controlled Open-label / Laryngeal Attack | 3 | |
| Controlled Phase | STARTED | Untreated Patients at the Baseline | 8 | |
| Controlled Phase | COMPLETED | Randomized Controlled -Icatibant | 26 | |
| Controlled Phase | COMPLETED | Randomized Controlled-Tranexamic Acid | 28 | |
| Controlled Phase | COMPLETED | Controlled Open-label / Laryngeal Attack | 2 | |
| Controlled Phase | COMPLETED | Untreated Patients at the Baseline | 0 | |
| Controlled Phase | NOT COMPLETED | Randomized Controlled -Icatibant | 10 | |
| Controlled Phase | NOT COMPLETED | Randomized Controlled-Tranexamic Acid | 10 | |
| Controlled Phase | NOT COMPLETED | Controlled Open-label / Laryngeal Attack | 1 | |
| Controlled Phase | NOT COMPLETED | Untreated Patients at the Baseline | 8 | |
| Open Label Extension (OLE) Phase | STARTED | Randomized Controlled -Icatibant | 23 | |
| Open Label Extension (OLE) Phase | STARTED | Randomized Controlled-Tranexamic Acid | 21 | |
| Open Label Extension (OLE) Phase | STARTED | Controlled Open-label / Laryngeal Attack | 2 | |
| Open Label Extension (OLE) Phase | STARTED | Untreated Patients at the Baseline | 8 | |
| Open Label Extension (OLE) Phase | COMPLETED | Randomized Controlled -Icatibant | 16 | |
| Open Label Extension (OLE) Phase | COMPLETED | Randomized Controlled-Tranexamic Acid | 9 | |
| Open Label Extension (OLE) Phase | COMPLETED | Controlled Open-label / Laryngeal Attack | 1 | |
| Open Label Extension (OLE) Phase | COMPLETED | Untreated Patients at the Baseline | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00500656/flow